Adult Acute Megakaryoblastic Leukemia
specificAn acute megakaryoblastic leukemia that occurs in adults.
47
Centers
15
Active Trials
—
Cancer Funding
Top Centers for Adult Acute Megakaryoblastic Leukemia(47)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 66.4 |
| 2 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 66.4 |
| 3 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 66.4 |
| 4 | NCI Comprehensive Active Research Program | 66.4 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 66.4 |
| 6 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 66.4 |
| 7 | NCI Clinical Active Research Program | 66.4 |
| 8 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 66.4 |
| 9 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 66.4 |
| 10 | University of Illinois Cancer CenterChicago, IL Active Research Program | 66.4 |
| 11 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 66.4 |
| 12 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 66.4 |
| 13 | Cancer Center at IllinoisUrbana, IL Active Research Program | 66.4 |
| 14 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 66.4 |
| 15 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 66.4 |
| 16 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 43.9 |
| 17 | NCI Comprehensive | 43.9 |
| 18 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive | 43.9 |
| 19 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive | 43.9 |
| 20 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 43.9 |
| 21 | NCI Comprehensive | 43.9 |
| 22 | NCI Comprehensive | 43.9 |
| 23 | NCI Comprehensive | 43.9 |
| 24 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 43.9 |
| 25 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 43.9 |
| 26 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 43.9 |
| 27 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive | 43.9 |
| 28 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 43.9 |
| 29 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | 43.9 |
| 30 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 43.9 |
| 31 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 43.9 |
| 32 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 43.9 |
| 33 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive | 43.9 |
| 34 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive | 43.9 |
| 35 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive | 43.9 |
| 36 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive | 43.9 |
| 37 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR | 43.9 |
| 38 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 43.9 |
| 39 | Boston University Cancer CenterBoston, MA | 43.9 |
| 40 | 43.9 | |
| 41 | Stony Brook Cancer CenterStony Brook, NY | 43.9 |
| 42 | Penn State Cancer InstituteHershey, PA | 43.9 |
| 43 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 43.9 |
| 44 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ | 43.9 |
| 45 | Georgia Cancer Center, Augusta UniversityAugusta, GA | 43.9 |
| 46 | The University of Vermont Cancer CenterBurlington, VT | 43.9 |
| 47 | Princess Margaret Cancer CentreToronto, ON | 43.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →